143 related articles for article (PubMed ID: 13679638)
21. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
22. CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo.
Igney FH; Behrens CK; Krammer PH
Int J Cancer; 2005 Jan; 113(1):78-87. PubMed ID: 15386427
[TBL] [Abstract][Full Text] [Related]
23. Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.
Krzyzowska M; Baska P; Grochowska A; Orlowski P; Nowak Z; Winnicka A
Immunobiology; 2014 Jan; 219(1):64-77. PubMed ID: 24028839
[TBL] [Abstract][Full Text] [Related]
24. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
25. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
Fecho K; Cohen PL
J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor.
Yoon- DY; Cho YS; Park JW; Kim SH; Kim JW
Clin Chem Lab Med; 2004 May; 42(5):499-506. PubMed ID: 15202785
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
[TBL] [Abstract][Full Text] [Related]
29. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3.
Seko Y; Kayagaki N; Seino K; Yagita H; Okumura K; Nagai R
J Am Coll Cardiol; 2002 Apr; 39(8):1399-403. PubMed ID: 11955862
[TBL] [Abstract][Full Text] [Related]
30. The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils.
Hsieh SC; Huang MH; Tsai CY; Tsai YY; Tsai ST; Sun KH; Yu HS; Han SH; Yu CL
Biochem Biophys Res Commun; 1997 Apr; 233(3):700-6. PubMed ID: 9168918
[TBL] [Abstract][Full Text] [Related]
31. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
[TBL] [Abstract][Full Text] [Related]
32. FasL gene therapy: a new therapeutic modality for head and neck cancer.
ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
[TBL] [Abstract][Full Text] [Related]
33. Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.
Gienau M; Hartmann KU
Thymus; 1997; 24(4):279-86. PubMed ID: 9493289
[TBL] [Abstract][Full Text] [Related]
34. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
35. Expression of Fas but not Fas ligand on fetal pig beta cells.
Bai L; Maedler K; Donath M; Tuch BE
Xenotransplantation; 2004 Sep; 11(5):426-35. PubMed ID: 15303979
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).
Drozdzik M; Qian C; Lasarte JJ; Bilbao R; Prieto J
Gene Ther; 1998 Dec; 5(12):1622-30. PubMed ID: 10023441
[TBL] [Abstract][Full Text] [Related]
37. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.
Hyer ML; Voelkel-Johnson C; Rubinchik S; Dong J; Norris JS
Mol Ther; 2000 Oct; 2(4):348-58. PubMed ID: 11020350
[TBL] [Abstract][Full Text] [Related]
38. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
39. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
40. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
